Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Detemir/Aspart Strategy in T2DM and NAFLD
NCT00998335Phase 4Completed
- Sponsor
- University of Florida
- Start
- Jun 2007
- Primary completion
- Feb 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin aspart in type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD), sponsored by University of Florida. Started Jun 2007; status: completed.
02
Drugs
insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT00998335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00998335.